Preliminary Recommendation on 0.1% Sodium Hyaluronate (15 mL) and 2.5% Peritoneal Dialysis Solution (2L and 5L)
effectiveness and safety of pazopanib in the management of metastatic soft tissue sarcoma post-chemotherapy
